AxonJay
ActiveSummary
The annual accounts of AxonJay for financial year 2025 show a net loss of 53% of total assets and of 263% of the equity at the start of that year. The 2025 annual accounts show equity of €348,902 and a net result of -€627,051. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 34% of 9,627 sector peers (NACE 82, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.1% (low).
Directors
Directors
No directors read yet: 4 of 15 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Capital and shareholders
Capital over the years
- 28-01-2025 Capital increase of €487,500 · 1,137 new shares
- 28-01-2025 Capital increase of €250,000 · 583 new shares · “inbreng zekere vaststaande opeisbare schuldvorderingen ten laste van Vennootschap”
- 09-07-2024 Capital increase of €1,175,000 · 3,008 new shares · in kind